Search - tctmd.com

Displaying 41 - 60 of 178

Sort: Relevancy | Date

Presentation TCT 2019

There Are No Circumstances in Which I Have to Use DCB/DES

Presenter: Konstantinos Katsanos

September 26, 2019

Presentation TCT 2019

Deciphering the FDA Guidance

Presenter: Mehdi Shishehbor

September 26, 2019

Presentation TCT 2019

Long Segment SFA CTO in a Claudicant

Presenter: Brian DeRubertis

September 26, 2019

Presentation TCT 2019

State of the Art Lecture: Novel Drug Delivery Technologies for the SFA

Presenter: Juan Granada

September 26, 2019

Presentation TCT 2019

Introduction and Session Objectives

Presenter: Sahil Parikh

September 26, 2019

Presentation TCT 2019

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Presenter: Christine Chung

September 25, 2019

Presentation TCT 2019

Case #2: Mitral Valve-in-MAC

Presenter: Stephanie El-Hajj

September 25, 2019

Presentation TCT 2019

Case #1: Complex TAVR ⁠— Bioprosthetic Valve Failure

Presenter: Maureen McKiernan

September 25, 2019

News Conference News EuroPCR 2019

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

Caitlin E. Cox

May 21, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Conference News PCR London Valves 2018

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

Shelley Wood

September 10, 2018

News Daily News

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Caitlin E. Cox

September 05, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Industry News

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

February 26, 2018

News Daily News

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

L.A. McKeown

February 07, 2018

News Industry News

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

May 25, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

Advertisement

There Are No Circumstances in Which I Have to Use DCB/DES

Deciphering the FDA Guidance

Long Segment SFA CTO in a Claudicant

State of the Art Lecture: Novel Drug Delivery Technologies for the SFA

Introduction and Session Objectives

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Case #2: Mitral Valve-in-MAC

Case #1: Complex TAVR ⁠— Bioprosthetic Valve Failure

Ultrathin Struts Show Strength in Small Vessels: BIO-RESORT at 3 Years

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Small Series Speak to Inching Progress in Off-Label or Expanded TAVR Applications

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

Medtronic Enrolls First Patient in Study of IN.PACT(TM) AV Access Drug-Coated Balloon in Patients with End-Stage Renal Disease

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content